Session Abstract – PMWC 2017 Silicon Valley
Session Synopsis: Precision medicine is empowered by access to diverse data, patients, and provider networks. This session will describe the role of health systems as translational research partners that can drive: 1) molecular discoveries; 2) provider and patient engagement through an interoperable platform; and 3) rapid translation of discoveries to clinical practice.
Session Chair Profile
Ph.D., MPH, Chief Research Officer, Sutter Health
Walter (Buzz) Stewart joined Sutter in July, 2012 and oversees research at Sutter organized around Digital Health and Advanced Analytics, Precision Medicine, Clinical Trials, and Rapid Health System Learning. His personal interests span the unique role of health system research in transforming care through predictive analytics, population health management, and digital health. Prior to Sutter, Buzz founded the Geisinger Center for Health Research (2003-2012) as part of Geisinger’s decade long strategy to transform the delivery of health care. Previously, he was a faculty member at the Johns Hopkins Bloomberg School of Public Health (1983-1995), was Vice President of Research and Development at AdvancePCS (1998-2002) and founded, managed, and successfully sold several start-ups. He has published more than 400 peer-reviewed articles and book chapters after receiving his PhD in Epidemiology from Johns Hopkins University, his MPH from UCLA, and his BS in Psychobiology from University of California, Riverside.
Ph.D., Sr. Epidemiologist and Executive Director, Research, Development, and Dissemination, Sutter Health
Dr. Liberman leads the teams responsible for designing and developing health care solutions and implementing the system-wide DNA and serum biobank. Prior to joining Sutter Health, Dr. Liberman was the Vice President, Research Operations, for the Center for Health Research at Geisinger Health System, where he directed the Center’s operations and developed research collaborations with clinical leaders in Neurosciences, Pediatrics, and Pulmonology. Dr. Liberman was the Vice President of Strategic Research with CVS Health, the largest integrated pharmacy company in the United States and the market leader in mail order; retail clinics; and Medicare Part D prescription drug plans. Dr. Liberman’s research focused on evaluating pharmacy benefit management services, barriers to generic drug and mail-service pharmacy use, and the value of medication adherence. He received his PhD in Epidemiology, School of Hygiene and Public Health; Master of Health Science in Occupational & Environmental Epidemiology; and Bachelor of Arts in Natural Science – Public Health, all from The Johns Hopkins University, Baltimore, Maryland.
Precision Care for MS: Making It Work
Precision Care is a Sutter R&D initiative to ensure patients receive the right care at the right time during ambulatory encounters. We’ve developed a digital platform that integrates applications that integrates in real time with EHRs to obtain PRO, automates visualizing an integrated display of patient data, and supports shared decision making.
Ph.D., Senior Scientist, Sutter Health, California Pacific Medical Center (CPMC) Research Institute
Dr. Gregory Tranah is also an Adjunct Professor in the Department of Epidemiology and Biostatistics at the University of California, San Francisco. He received his PhD in Ecology from University of California, Davis and was a postdoctoral fellow in Epidemiology at the Harvard School of Public Health. Dr. Tranah’s current research program is focused on identifying inherited and acquired genetic factors that impact aging and disease with the goal of revolutionizing risk assessment and identifying widely applicable genomic tests that identify persons who would benefit from specific pharmacologic and behavioral treatments to prevent disability and disease. He is the principal investigator of several NIH grants and Sutter-CPMC Foundation grants. Dr. Tranah is the Genetics Director for several large population-based epidemiologic cohorts and is actively conducting large-scale genomic analyses in collaboration with several consortia focused on aging and disease. At the CPMC Research Institute he directs the genomics core of the Personalized Medicine program which is focused on identifying genomic predictors of treatment response for several highly malignant cancers. Dr. Tranah is currently leading a research program dedicated to accelerating the translation of research discoveries related to health and aging to clinical settings across Sutter Health and is applying this experience to the development of the Sutter Health Precision Medicine Program.
Precision Medicine: Making It Work on Scale
Sutter Precision Medicine program will be launching an integrated health system pipeline that simplifies and reduces the cost of banking patient biological samples and supports ready access to EHR and patient generated data to enhance identification of disease phenotypes and support partnerships to improve early detection of disease progression, treatment diagnostics, and development of new therapeutics.